Symbolbild · KI-generiert
Intellia Therapeutics, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Intellia Therapeutics develops CRISPR/Cas9-based genome editing therapies for the permanent treatment of disease. The company pursues both in vivo and ex vivo approaches, with a focus on rare genetic conditions such as transthyretin-mediated amyloidosis. Intellia works with partners including Regeneron.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Intellia Therapeutics, Inc. | NTLA | NASDAQ | 1,49 Mrd. USD |
| Maze Therapeutics, Inc. | MAZE | NASDAQ | 1,49 Mrd. USD |
| Xencor, Inc. | XNCR | NASDAQ | 1,50 Mrd. USD |
| Alphatec Holdings, Inc. | ATEC | NASDAQ | 1,46 Mrd. USD |
| Vir Biotechnology, Inc. | VIR | NASDAQ | 1,46 Mrd. USD |
| Green Thumb Industries Inc. | GTII | CSE | 1,46 Mrd. USD |
| BioLife Solutions, Inc. | BLFS | NASDAQ | 1,53 Mrd. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.